Pfizer Inc. (PFE) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 14.45B | 17.56B | 16.65B | 14.65B | 13.71B | 17.76B | 17.7B | 13.28B | 14.88B | 14.57B | 13.49B | 13.01B |
| Revenue Growth % | 5.37% | -1.16% | -5.92% | 10.31% | -7.82% | 21.91% | 31.21% | 2.12% | -19.51% | -40.02% | -40.41% | -53.11% |
| Cost of Goods Sold | 4.73B | 5.27B | 4.17B | 5.23B | 3.89B | 4.79B | 6.93B | 5.04B | 4.38B | 8.59B | 10.6B | 4.59B |
| COGS % of Revenue | 32.74% | 30.03% | 25.05% | 35.71% | 28.35% | 26.99% | 39.15% | 37.94% | 29.44% | 58.96% | 78.59% | 35.33% |
| Gross Profit | 9.72B | 12.29B | 12.48B | 9.42B | 9.83B | 12.97B | 10.77B | 8.24B | 10.5B | 5.98B | 2.89B | 8.41B |
| Gross Margin % | 67.26% | 69.97% | 74.95% | 64.29% | 71.65% | 73.01% | 60.85% | 62.06% | 70.56% | 41.04% | 21.41% | 64.67% |
| Gross Profit Growth % | -1.09% | -5.27% | 15.89% | 14.28% | -6.39% | 116.86% | 272.96% | -2.01% | -16.26% | -55.34% | -81.55% | -54.96% |
| Operating Expenses | 5.69B | 8.6B | 8.93B | 5.84B | 5.2B | 7.24B | 5.8B | 6.36B | 5.94B | 7.24B | 5.89B | 6.06B |
| OpEx % of Revenue | 39.36% | 48.97% | 53.63% | 39.89% | 37.94% | 40.78% | 32.78% | 47.91% | 39.92% | 49.71% | 43.69% | 46.6% |
| Selling, General & Admin | 2.96B | 3.73B | 3.19B | 3.4B | 3.02B | 4.23B | 3.24B | 3.69B | 3.46B | 4.47B | 3.21B | 3.43B |
| SG&A % of Revenue | 20.49% | 21.27% | 19.13% | 23.22% | 22.05% | 23.79% | 18.29% | 27.76% | 23.25% | 30.68% | 23.81% | 26.39% |
| Research & Development | 2.63B | 3.42B | 3.94B | 2.44B | 2.18B | 3.02B | 2.56B | 2.68B | 2.48B | 2.77B | 2.68B | 2.63B |
| R&D % of Revenue | 18.18% | 19.47% | 23.63% | 16.67% | 15.89% | 16.98% | 14.49% | 20.15% | 16.67% | 19.03% | 19.88% | 20.21% |
| Other Operating Expenses | 1000K | 1000K | 1000K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | 4.03B | 3.69B | 3.55B | 3.58B | 4.62B | 5.72B | 4.97B | 1.88B | 4.56B | -1.26B | -3.01B | 2.35B |
| Operating Margin % | 27.9% | 21.01% | 21.32% | 24.4% | 33.71% | 32.23% | 28.06% | 14.15% | 30.64% | -8.67% | -22.28% | 18.07% |
| Operating Income Growth % | -12.8% | -35.58% | -28.54% | 90.26% | 1.43% | 553.29% | 265.27% | -20.08% | -31.8% | -123.62% | -130.99% | -81.84% |
| EBITDA | 5.21B | 5.38B | 5.21B | 5.2B | 6.24B | 7.52B | 6.72B | 3.61B | 6.29B | 407M | -1.45B | 3.92B |
| EBITDA Margin % | 36.09% | 30.61% | 31.3% | 35.49% | 45.51% | 42.31% | 37.98% | 27.18% | 42.31% | 2.79% | -10.72% | 30.17% |
| EBITDA Growth % | -16.45% | -28.49% | -22.48% | 44.04% | -0.84% | 1746.68% | 564.94% | -8% | -22.97% | -94.07% | -113.29% | -72.21% |
| D&A (Non-Cash Add-back) | 1.18B | 1.69B | 1.66B | 1.63B | 1.62B | 1.79B | 1.75B | 1.73B | 1.74B | 1.67B | 1.56B | 1.57B |
| EBIT | 4.03B | -931M | 3.99B | 3.7B | 3.44B | 3.35B | 5.5B | 674M | 4.21B | -3.44B | -2.66B | 2.78B |
| Net Interest Income | -554M | -545M | -514M | -498M | -511M | -569M | -667M | -648M | -661M | -80M | -172M | -192M |
| Interest Income | 115M | 166M | 138M | 156M | 143M | 170M | 116M | 130M | 129M | 609M | 523M | 316M |
| Interest Expense | 668M | 711M | 652M | 654M | 654M | 739M | 783M | 778M | 790M | 689M | 695M | 508M |
| Other Income/Expense | -862M | -5.33B | -216M | -531M | -1.84B | -5.74B | -253M | -1.98B | -1.14B | -2.87B | -346M | -82M |
| Pretax Income | 3.17B | -1.64B | 3.33B | 3.04B | 2.78B | -10M | 4.71B | -103M | 3.42B | -4.13B | -3.35B | 2.27B |
| Pretax Margin % | 21.94% | -9.35% | 20.02% | 20.77% | 20.3% | -0.06% | 26.64% | -0.78% | 22.99% | -28.34% | -24.85% | 17.44% |
| Income Tax | 461M | -2M | -216M | 141M | -189M | -421M | 234M | -134M | 293M | -794M | -964M | -71M |
| Effective Tax Rate % | 14.54% | 0.12% | -6.48% | 4.63% | -6.79% | 4210% | 4.96% | 130.1% | 8.56% | 19.23% | 28.76% | -3.13% |
| Net Income | 2.69B | -1.65B | 3.54B | 2.91B | 2.97B | 403M | 4.47B | 24M | 3.12B | -3.34B | -2.39B | 2.33B |
| Net Margin % | 18.6% | -9.39% | 21.26% | 19.86% | 21.63% | 2.27% | 25.27% | 0.18% | 20.97% | -22.94% | -17.75% | 17.91% |
| Net Income Growth % | -9.4% | -508.93% | -20.84% | 12025% | -4.9% | 112.05% | 286.84% | -98.97% | -43.7% | -166.95% | -127.74% | -76.41% |
| Net Income (Continuing) | 2.71B | -1.64B | 3.55B | 2.9B | 2.97B | 411M | 4.48B | 31M | 3.13B | -3.33B | -2.39B | 2.34B |
| Discontinued Operations | -1000K | 0 | 0 | 1000K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 303M | 299M | 295M | 317M | 299M | 294M | 272M | 275M | 276M | 274M | 270M | 274M |
| EPS (Diluted) | 0.47 | -0.29 | 0.62 | 0.51 | 0.52 | 0.07 | 0.78 | 0.00 | 0.55 | -0.60 | -0.42 | 0.41 |
| EPS Growth % | -9.55% | -503.34% | -20.92% | - | -5.13% | 112.05% | 284.91% | -98.97% | -43.4% | -168.64% | -128.1% | -76.41% |
| EPS (Basic) | 0.47 | -0.29 | 0.62 | 0.51 | 0.52 | 0.07 | 0.79 | 0.00 | 0.55 | -0.60 | -0.42 | 0.41 |
| Diluted Shares Outstanding | 5.73B | 5.69B | 5.71B | 5.71B | 5.71B | 5.7B | 5.71B | 5.7B | 5.7B | 5.65B | 5.65B | 5.71B |
| Basic Shares Outstanding | 5.69B | 5.68B | 5.68B | 5.68B | 5.67B | 5.67B | 5.67B | 5.67B | 5.66B | 5.65B | 5.65B | 5.65B |
| Dividend Payout Ratio | 90.96% | - | 69.02% | 84.02% | 82.14% | 590.57% | 53.21% | 9916.67% | 76.03% | - | - | 99.4% |